Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies NCT00186823 Leukemia, Acute...
Leukemia, Myelo...
Leukemia, Myelo...
Juvenile Myelom...
Hemoglobinuria,...
Lymphoma, Non-H...
Myelodysplastic...
Miltenyi Biotec...
Stem Cell Trans...
TBI, systemic c...
2 Years - 21 Years St. Jude Children's Research Hospital View Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases NCT02145039 Acute Leukemias
Burkitt's Lymph...
Chronic Myeloge...
Fludarabine
Cyclophosphamid...
Total Body Irra...
Haploidentical ...
- 74 Years Masonic Cancer Center, University of Minnesota View Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies NCT00145613 Acute Lymphobla...
Acute Myeloid L...
Secondary AML
Myelodysplastic...
Secondary MDS
Chronic Myeloid...
Juvenile Myelom...
Paroxysmal Noct...
Lymphoma, Non-H...
Hodgkin Disease
Stem Cell Trans...
Miltenyi Biotec...
Systemic chemot...
2 Years - 21 Years St. Jude Children's Research Hospital View Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies NCT00566696 Leukemia, Acute...
Leukemia, Myelo...
Leukemia, Myelo...
Juvenile Myelom...
Hemoglobinuria,...
Hodgkin Lymphom...
Lymphoma, Non-H...
Myelodysplastic...
CliniMACS
Stem cell trans...
Fludarabine
Thioplex®
L-phenylalanine...
Mycophenolate m...
Rituxan™
Alemtuzumab
Cyclophosphamid...
Anti-thymocyte ...
G-CSF
Muromonab
- 21 Years St. Jude Children's Research Hospital View Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies NCT00566696 Leukemia, Acute...
Leukemia, Myelo...
Leukemia, Myelo...
Juvenile Myelom...
Hemoglobinuria,...
Hodgkin Lymphom...
Lymphoma, Non-H...
Myelodysplastic...
CliniMACS
Stem cell trans...
Fludarabine
Thioplex®
L-phenylalanine...
Mycophenolate m...
Rituxan™
Alemtuzumab
Cyclophosphamid...
Anti-thymocyte ...
G-CSF
Muromonab
- 21 Years St. Jude Children's Research Hospital View Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies NCT00145613 Acute Lymphobla...
Acute Myeloid L...
Secondary AML
Myelodysplastic...
Secondary MDS
Chronic Myeloid...
Juvenile Myelom...
Paroxysmal Noct...
Lymphoma, Non-H...
Hodgkin Disease
Stem Cell Trans...
Miltenyi Biotec...
Systemic chemot...
2 Years - 21 Years St. Jude Children's Research Hospital View Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases NCT02145039 Acute Leukemias
Burkitt's Lymph...
Chronic Myeloge...
Fludarabine
Cyclophosphamid...
Total Body Irra...
Haploidentical ...
- 74 Years Masonic Cancer Center, University of Minnesota View Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies NCT00143559 Leukemia
Acute Lymphobla...
Acute Myeloid L...
Chronic Myeloid...
Juvenile Myelom...
Myelodysplastic...
Paroxysmal Noct...
Hodgkin's Lymph...
Non-Hodgkin Lym...
Systematic chem...
Allogeneic stem...
Miltenyi CliniM...
2 Years - 21 Years St. Jude Children's Research Hospital View Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases NCT02145039 Acute Leukemias
Burkitt's Lymph...
Chronic Myeloge...
Fludarabine
Cyclophosphamid...
Total Body Irra...
Haploidentical ...
- 74 Years Masonic Cancer Center, University of Minnesota View